Shareholder Sandra Frantzen Recognized in the IAM Patent 1000
07.15.26
IAM featured Sandra in the 2026 IAM Patent 1000 Guide for her work assisting clients ranging from start-ups to Fortune 500 companies with resolving intellectual property disputes and managing high-stakes technology matters.
IAM said, “… Sandra Frantzen is a seasoned trial lawyer and PTAB advocate who handles patent disputes across the life sciences sector. Her work frequently spans district court litigation, inter partes review proceedings, and appellate matters, particularly in cases involving pharmaceutical and medical device technologies. [One client commented that] ‘Sandra pairs strategic foresight with clear, effective communication and a deeply client-focused approach.’”
Read more here: https://bit.ly/4eVQxqg (subscription required)